Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1607
    -0.0076 (-0.65%)
     
  • GBP/USD

    1.2370
    -0.0068 (-0.55%)
     
  • Bitcoin GBP

    51,376.18
    +1,177.20 (+2.35%)
     
  • CMC Crypto 200

    1,366.37
    +53.74 (+4.09%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     
  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

Virbac : Availability of the quarterly financial information as of September 30, 2017

Virbac:
Availability of the quarterly financial information as of September 30, 2017

Public release - November 14th, 2017

The quarterly financial information as of September 30, 2017 is available:

· on our website: corporate.virbac.com under the section Investors - Financial reports - 2017,

or

· on request, under legal and regulatory conditions.

In accordance with the amendments implemented by the French financial markets authority (AMF), this document presents:

· significant operations and events of the period,

· a description of the group financial standing,

· the turnover distribution by segment.

NYSE Euronext - compartiment A - code ISIN: FR0000031577 / MNEMO: VIRP
Corporate Finance: tél. 33 4 92 08 71 32 - e-mail: finances@virbac.com
Website: corporate.virbac.com
Virbac - Shaping the future of animal health

ADVERTISEMENT

Virbac: Availability quarterly financial information Sept 30, 2017



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Virbac via GlobeNewswire

HUG#2149800